Traders bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Thursday. $543.15 million flowed into the stock on the tick-up and $469.43 million flowed out of the stock on the tick-down, for a money net flow of $73.72 million into the stock. Of all companies tracked, UnitedHealth Group had the 5th highest net in-flow for the day. UnitedHealth Group traded down ($10.61) for the day and closed at $235.42
UNH has been the subject of a number of research reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a research note on Tuesday, January 15th. Credit Suisse Group reiterated a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a research note on Friday, February 8th. Argus increased their price objective on UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a report on Monday, December 17th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $305.00 price objective for the company in a report on Friday, December 14th. Finally, Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Three investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $297.80.
The firm has a market cap of $236.08 billion, a price-to-earnings ratio of 18.28, a price-to-earnings-growth ratio of 1.27 and a beta of 0.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $0.90 per share. The ex-dividend date was Friday, March 8th. This represents a $3.60 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is currently 27.95%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total value of $1,333,050.00. Following the sale, the director now owns 77,702 shares of the company’s stock, valued at $20,716,130.22. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,930 shares of company stock valued at $8,495,383. Company insiders own 0.87% of the company’s stock.
A number of institutional investors have recently modified their holdings of the business. Advisor Partners LLC grew its stake in shares of UnitedHealth Group by 6.5% in the 4th quarter. Advisor Partners LLC now owns 31,893 shares of the healthcare conglomerate’s stock valued at $7,945,000 after buying an additional 1,949 shares during the period. TIAA CREF Investment Management LLC lifted its position in UnitedHealth Group by 7.3% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after acquiring an additional 370,179 shares in the last quarter. Financial Enhancement Group LLC lifted its position in UnitedHealth Group by 2,579.3% in the 3rd quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock valued at $413,000 after acquiring an additional 1,496 shares in the last quarter. Legacy Bridge LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $824,000. Finally, LS Investment Advisors LLC lifted its position in UnitedHealth Group by 38.9% in the 4th quarter. LS Investment Advisors LLC now owns 34,921 shares of the healthcare conglomerate’s stock valued at $8,700,000 after acquiring an additional 9,784 shares in the last quarter. Hedge funds and other institutional investors own 86.68% of the company’s stock.
UnitedHealth Group Company Profile (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Cost of Capital Explained
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.